Despite the global editing loss observed in GBM, we found that a few recoding sites (12 sites) were over-edited in cancer, with the top sites being CADPS E/G (+ 17% Δ medians) and COG3 I/V (+ 17% Δ median). The gene discussed is COG3; the disease is glioblastoma.